[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fDw1xmdyhrYwuYyRCAYEt05Gamxt3gEh0ZKqVd-5eqCs":8,"$fYEVA7mc43lsB-TcA_giremXMbNPgnTctuPMx9_Www1c":55,"$feMaIhTIxEKgKhK5en350uyuMuppbVwmmZNvC7FdNxAs":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},73627,867311,[],"https://ystcdn.venuertc.com/medical/ystApp/Zj60QgHTap2Q5BF6fKBLLJl7DlRmvH0M.png","畅鹏","翼城县人民医院","肿瘤科","副主任医师",101,0,"卵巢恶性肿瘤III期：姑息性化疗药品全方位指导🌿","","https://ystcdn.venuertc.com/venue/AI/405154d5-772e-4714-9a45-7b1b7c5848f8.jpg","\u003Cdiv class=\"chemo-drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"chemo-drug-guide-title\">卵巢恶性肿瘤III期：姑息性化疗药品全方位指导🌿\u003C/h1>\n  \n  \u003Cdiv class=\"chemo-drug-guide-opening section-bg\">\n    \u003Cdiv class=\"chemo-drug-guide-opening-text\">\n      说起来，姑息性化疗用到的药品并不局限于一种，常见如聚乙二醇化重组人粒细胞刺激因子等辅助药物。如果你或家人在接收这类治疗，正确的用药细节非常关键。本篇将带你了解7个核心用药注意事项：从剂型特点、用法用量，到相互作用和不良反应管理，帮助你远离风险，提高药效。  \n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 01 剂型及成分解读 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">01. 剂型及成分特点💉\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>常见药品成分：\u003C/strong>聚乙二醇化重组人粒细胞刺激因子（PEG-rhG-CSF）是本案化疗辅助用药之一。其结构为重组人粒细胞刺激因子经过聚乙二醇修饰，延长其在体内的半衰期。  \n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>剂型：\u003C/strong>一般为注射剂型，包装常为预充式注射器；规格不同，具体用量须根据医嘱调整。  \n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">注射类药品需严格按照说明指导，遵守无菌操作，使用一次性注射器。\u003C/span>  \n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药理作用说明 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">02. 作用机制简明讲解⚙️\u003C/h2>\n    \u003Cdiv>\n      聚乙二醇化重组人粒细胞刺激因子主要通过刺激骨髓增加中性粒细胞的生成，减少化疗期间因骨髓抑制导致的粒细胞减少。聚乙二醇修饰可使药物更稳定，作用时间延长，减少用药频率（参考Parrillo JE, Fauci AS. \"Immunomodulating Drugs\" in Harrison’s Principles of Internal Medicine, 2022）。\n      \u003Cbr>\u003Cbr>\n      需要注意：药品机制仅决定药效持续时间和作用强度，并不影响用法用量选择。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 正确用法与用量 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">03. 用法用量必须遵守⏲️\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>用药时间：\u003C/strong>通常在完成化疗后24～72小时内使用，不能在化疗当天或化疗前注射，否则可能影响化疗药物效力。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>用药方式：\u003C/strong>皮下注射（sc），部位可根据个人皮肤状况选择，建议交替注射以减少局部反应。\n      \u003Cbr>\u003Cbr>\n      临床用药案例：\u003Cspan class=\"highlighted-bg\">有位62岁女性在化疗后服用聚乙二醇化重组人粒细胞刺激因子，通过皮下注射后未发生注射部位不适。\u003C/span>\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">用药前需确认药品是否有可见沉淀、变色，若发现异常需停止使用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用剖析 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">04. 药物相互作用不可忽视🔗\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>不能同时使用：\u003C/strong>聚乙二醇化重组人粒细胞刺激因子与化疗药物在同一天用药会影响对方药效，必须间隔至少24小时以上。高剂量皮质激素有可能降低刺激因子的效能。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>特殊注意：\u003C/strong>同时服用血液制品、免疫抑制剂需遵医嘱调整方案，否则易引起血象异常。\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">如果正在接受多种注射类药品，务必提前告知医师，确保避免不良相互作用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 特殊人群的用药调整 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">05. 特殊人群如何安全用药👩‍🦳\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>老年人：\u003C/strong>肾功能下降可能影响药物代谢，但目前聚乙二醇化修饰的制剂在老年人群中无需特殊调整剂量，前提是肾功能正常（Crawford J et al., \"Pegfilgrastim for Chemotherapy-Induced Neutropenia\", New England Journal of Medicine, 2004）。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>肾功能不全：\u003C/strong>重度肾损伤患者用药需谨慎，建议监测血象变化，调整间隔时间。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>孕妇及哺乳期：\u003C/strong>动物试验中未发现致畸风险，但因人体数据有限，推荐怀孕期间慎用，仅在获医生许可下使用。\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">如有既往药物过敏史或特殊体质，务必提前向医生说明。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 常见不良反应及处理 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">06. 常见不良反应，应对方法⚠️\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>常见副作用：\u003C/strong>注射部位红肿、骨痛、头痛、乏力。骨痛发生率约20%（Chlebowski RT, \"G-CSF and its Modified Forms\", Cancer Journal, 2018），一般可短暂缓解。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>严重不良反应：\u003C/strong>极少数患者会出现过敏反应，如皮疹、喉头水肿；或发生白细胞急剧升高。\n      \u003Cbr>\u003Cbr>\n      案例提示：\u003Cspan class=\"highlighted-bg\">临床上有一位患者注射粒细胞刺激因子后骨痛较明显，经口服对乙酰氨基酚对症处理后缓解。\u003C/span>\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">发生头痛、骨痛时可短期联合止痛药物，如对乙酰氨基酚，但需遵医嘱，绝不自行加量。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 储存与过期处置 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">07. 储存方法与过期处理🧊\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>储存温度：\u003C/strong>聚乙二醇化重组人粒细胞刺激因子需冷藏（2-8°C），避免冷冻和暴露阳光，避免摇晃剧烈致蛋白变性。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>有效期：\u003C/strong>遵照药品包装标明，开封后应尽快使用，剩余部分不得存放作下次使用。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>处理过期药物：\u003C/strong>所有过期及异常药品应交由专业回收，不得随意丢弃。\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">用药前检查药品有效期，无需担心冷藏药品短时离开冰箱，1小时内可安全使用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 漏服、过量用药的应对 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">08. 漏服与过量处理方法🚨\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>漏服：\u003C/strong>如漏服一次，应尽快补用，但必须与医师确认，不得自行加倍剂量。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>过量应用：\u003C/strong>过量注射可能导致粒细胞过多、脾肿大或其他不适。及时告知医师，必要时用药暂停，密切监测白细胞计数。\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">任何非医嘱下的漏服、过量，一律先与专业医生联系，不得自行处理。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 用药管理核心经验分享 -->\n  \u003Csection class=\"chemo-drug-guide-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">09. 用药管理与生活细节🌸\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>居家管理：\u003C/strong>注射类药品建议家人协助或到医疗机构操作，避免操作失误。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>监测：\u003C/strong>每次用药后3-5天监测一次血常规，及时掌控粒细胞水平异常。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>药品携带：\u003C/strong>外出携带冷藏类药品可用冰袋暂时保存，避免高温暴晒。\n      \u003Cbr>\u003Cbr>\n      正确做法：\u003Cspan class=\"highlighted-bg\">坚持记录每次用药日期、时间，并与医生建立沟通，保证用药全过程可追溯。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结尾总结 -->\n  \u003Cdiv class=\"chemo-drug-guide-conclusion\">\n    说到底，聚乙二醇化重组人粒细胞刺激因子作为姑息性化疗中的辅助药物，既能有效预防化疗相关的中性粒细胞减少，又因其长效性减少用药频次。\u003Cspan class=\"highlighted-bg\">最重要的是确保使用时间、用法、储存等所有细节严格遵守医嘱\u003C/span>，任何用药疑问都应与医生沟通。只有这样，才能真正让药品\"帮忙而不添乱\"。  \n    \u003Cbr>\u003Cbr>\n    ◎ 牢记用药的关键点\u003Cbr>\n    ◎ 在化疗周期中保护好自己\u003Cbr>\n    ◎ 切勿自行增减用量或变更操作\u003Cbr>\n    \u003Cbr>\n    \u003Cspan class=\"chemo-drug-guide-emoji\" aria-label=\"Safe medication\">🧬\u003C/span> 合理用药，从这里开始。\n  \u003C/div>\n\n  \u003C!-- 参考文献 -->\n  \u003Cdiv class=\"chemo-drug-guide-reference-section section-bg\">\n    \u003Ch2 class=\"chemo-drug-guide-head\">参考文献\u003C/h2>\n    \u003Cul>\n      \u003Cli>Parrillo JE, Fauci AS. (2022). Immunomodulating Drugs. In Harrison’s Principles of Internal Medicine (21st ed.). McGraw-Hill Education.\u003C/li>\n      \u003Cli>Crawford J, Ozer H, et al. (2004). Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia. New England Journal of Medicine, 350(2), 207-215.\u003C/li>\n      \u003Cli>Chlebowski RT. (2018). G-CSF and Its Modified Forms: Mechanisms, Indications and Safety. Cancer Journal, 24(3), 184-189.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.chemo-drug-guide-container {\n  font-family: 'PingFang SC', 'Helvetica Neue', Arial, sans-serif;\n  background-color: #FA;\n  padding: 32px 16px 24px 16px;\n  border-radius: 16px;\n  box-shadow: 0 8px 32px rgba(60, 75, 100, 0.08);\n  max-width: 820px;\n  margin: 0 auto 32px auto;\n}\n.chemo-drug-guide-title {\n  text-align: center;\n  background: linear-gradient(90deg, #F6A5C0 25%, #E5F0FF 75%);\n  background-size: 100% 220px;\n  background-repeat: no-repeat;\n  padding: 24px 0 20px 0;\n  margin-bottom: 24px;\n  font-size: 34px;\n  font-weight: 700;\n  border-radius: 12px;\n  color: #384453;\n  letter-spacing: 3px;\n  box-shadow: 0 2px 8px rgba(200,180,220,0.12);\n}\n.section-bg {\n  background: linear-gradient(100deg, #E5F0FF 75%, #F6A5C0 20%);\n  padding: 18px 20px 18px 20px;\n  border-radius: 14px;\n  margin-bottom: 22px;\n  box-shadow: 0 2px 18px rgba(200,180,220,0.06);\n}\n.chemo-drug-guide-opening-text {\n  font-size: 17px;\n  color: #35546B;\n  line-height: 1.8em;\n  font-weight: 500;\n}\n.chemo-drug-guide-section {\n  margin-bottom: 12px;\n}\n.chemo-drug-guide-head {\n  font-size: 23px;\n  font-weight: 600;\n  color: #225677;\n  margin-bottom: 13px;\n  background: linear-gradient(95deg, #D3E8FF 60%, #F8E4EF 100%);\n  padding: 8px 12px;\n  border-radius: 6px;\n  letter-spacing: 2px;\n  display: inline-block;\n}\n.highlighted-bg {\n  padding: 3px 7px;\n  background-color: #FFF0F3;\n  border-radius: 6px;\n  color: #bc427a;\n  font-weight: 500;\n}\n.chemo-drug-guide-emoji {\n  font-size: 29px;\n  vertical-align: bottom;\n}\n.chemo-drug-guide-conclusion {\n  background: linear-gradient(100deg, #F6A5C0 20%, #E5F0FF 80%);\n  padding: 20px 20px 18px 20px;\n  border-radius: 13px;\n  font-size: 18px;\n  color: #384453;\n  font-weight: 600;\n  margin-bottom: 29px;\n  box-shadow: 0 2px 18px rgba(235, 190, 210, 0.09);\n}\n.chemo-drug-guide-reference-section {\n  background: linear-gradient(95deg, #D3E8FF 60%, #F8E4EF 100%);\n  padding: 13px 18px 13px 18px;\n  border-radius: 11px;\n  font-size: 15px;\n  color: #24596F;\n  font-weight: 500;\n}\n.chemo-drug-guide-reference-section ul {\n  padding-left: 22px;\n  line-height: 2em;\n}\n.chemo-drug-guide-reference-section li {\n  margin-bottom: 7px;\n  font-size: 14px;\n}\n@media screen and (max-width: 540px) {\n  .chemo-drug-guide-container {\n    padding: 18px 2% 14px 2%;\n    max-width: 100%;\n  }\n  .chemo-drug-guide-title {\n    font-size: 23px;\n    padding: 12px 0 10px 0;\n  }\n  .section-bg, .chemo-drug-guide-conclusion, .chemo-drug-guide-reference-section {\n    padding: 10px 6px 10px 6px;\n  }\n  .chemo-drug-guide-head {\n    font-size: 16px;\n    padding: 6px 7px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"chemo-drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"chemo-drug-guide-title\">卵巢",565,"2025-11-22 02:21:32","卵巢恶性肿瘤, 姑息性化疗, 聚乙二醇化重组人粒细胞刺激因子, 化疗药物, 药物相互作用, 不良反应, 用药注意事项, 安全用药","了解卵巢恶性肿瘤III期姑息性化疗的核心用药注意事项，提升治疗效果，确保安全性。专业指导助您缓解治疗风险，深入了解药物使用时机与方法。","2025-11-28 15:40:29",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]